Original Article
Analysis of prognostic factors in patients with hepatocellular carcinoma (≤5 cm) underwent hepatectomy
Rong Weiqi, Yu Weibo, Wu Jianxiong, Wu Fan, Wang Liming, Tian Fei, An Songlin, Feng Li
Published 2016-02-01
Cite as Chin J Surg, 2016, 54(2): 89-93. DOI: 10.3760/cma.j.issn.0529-5815.2016.02.003
Abstract
ObjectiveTo explore the clinical and pathological factors influencing the prognosis of patients with hepatocellular carcinoma (HCC)(≤5 cm) after hepatectomy.
MethodsTwo hundreds and nineteen cases with HCC(≤5 cm) undergoing hepatectomy in Cancer Hospital, Chinese Academy of Medical Sciences between December 2003 and July 2013 were collected. The alpha fetoprotein (AFP) level, tumor number, tumor size (diameter), liver cirrhosis, vascular invasion, capsular invasion, differentiation, surgical methods, resection margin, the way of treatments, the situation of recurrence and time to recurrence were analyzed. Log-rank test and the stepwise Cox proportional-hazards models were used to compare the prognosis, respectively.
ResultsThe 1-, 3-, 5- and 10- year overall survival rates were 95.9%, 85.3%, 67.8% and 53.3% respectively in all patients.Single factor analysis indicated that vascular invasion, capsular invasion, tumor size, hepatic vascular occult, liver cirrhosis, tumor differentiation, AFP, the way of treatments, the situation of recurrence and time to recurrence can affect the prognosis significantly (all P<0.05). The multifactor analysis showed that AFP, tumor differentiation, liver cirrhosis, capsular invasion, tumor size and the situation of recurrence and time to recurrence were independent prognostic factors (allP<0.05).
ConclusionThe prognosis of patients with HCC(≤5 cm) underwent hepatectomy are affected by multi-factors, such as AFP, tumor differentiation, liver cirrhosis, capsular invasion, tumor size and the situation of recurrence and time to recurrence.
Key words:
Liver neoplasms; Hepatectomy; Prognosis; Risk factors
Contributor Information
Rong Weiqi
Department of Abdominal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Yu Weibo
Wu Jianxiong
Wu Fan
Wang Liming
Tian Fei
An Songlin
Feng Li